LLYEli Lilly and Company
1000.00CHF0.00%Mkt Cap: 1.02T $P/E: 41.32

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, incl…

Key Statistics

Company
Market Cap1.02T $
Enterprise Value1.04T $
Revenue (TTM)90.92B $
Gross Profit61.78B $
Net Income (TTM)23.56B $
Revenue/Share101.60 USD
Last Price1000.00 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees50.0K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS5324571083
Valuation
P/E (Trailing)41.32
P/E (Forward)
PEG1.55
EV/EBITDA21.94
EV/Revenue11.49
P/S10.91
P/B31.52
EPS (TTM)23.79
EPS (Forward)
52W Range
975.00100% of range1000.00
52W High1000.00 CHF
52W Low975.00 CHF
Profitability
Gross Margin83.04%
Oper. Margin54.22%
EBITDA Margin52.35%
Profit Margin31.67%
ROE77.78%
ROA18.35%
Growth
Revenue Growth47.70%
Earnings Growth26.20%
Cash Flow & Leverage
Operating CF19.19B $
CapEx (TTM)12.38B $
FCF Margin13.89%
FCF Yield1.24%
Net Debt52.45B $
Net Debt/EBITDA1.10
Balance Sheet
Debt/Equity1.60
Current Ratio1.35
Quick Ratio0.68
Book Value/Sh30.93 CHF
Cash/Share10.04 CHF
Dividends
Fwd Div Rate5.630 CHF
Trail. Div Rate6.460 CHF
Div. Yield0.56%
5Y Avg Yield0.88%
Payout Ratio21.69%
Ex-Div DateAug 14, 2026
Pay DateJun 10, 2025
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.891.36M
Float888.95M
Insiders0.16%
Institutions85.57%
Technical
SMA 50946.30 (+5.7%)
SMA 200835.17 (+19.7%)
Beta0.51
S&P 52W Chg20.80%
Avg Vol (30d)16
Avg Vol (10d)4
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)